Live feed
Filing
SC 13D/A
SC 13D/A0001104659-24-078084·Juvenescence Ltd
Schedule 13D ownership disclosure
AGEX THERAPEUTICS INC
Security class unavailable · CUSIP: 00848H108
Event date: 2024-06-06
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 38.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-078084
- Form type
- SC 13D/A
- Filer
- Juvenescence Ltd
- CIK
- CIK 1724307
- Filed
- Jul 05, 2024
- Reporting period
- Jun 06, 2024
- Description
- Schedule 13D beneficial ownership